NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to restore skin color in vitiligo patients
Disease control OngoingThis study is testing whether an oral medication called povorcitinib can help restore skin color in adults with nonsegmental vitiligo. About 450 participants will take either the drug or a placebo for 52 weeks to see how well it works on facial and body patches. Researchers will …
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill aims to restore skin color in vitiligo patients
Disease control OngoingThis Phase 3 trial is testing whether an oral medication called povorcitinib can help restore skin color in adults with nonsegmental vitiligo. Over 450 participants will take either the drug or a placebo for 52 weeks to see how well it reduces white patches on the face and body a…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC